Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune response in prostate cancer.

C M Cracco1, C Terrone, F Porpiglia

  • 1Division of Urology, Azienda Sanitaria Ospedaliera S. Luigi, University of Turin, Turin, Italy.

Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|October 26, 2005
PubMed
Summary

Prostate cancer, despite its hormonal basis, interacts with the immune system. Emerging research explores immunotherapy, including gene, antibody, and vaccine therapies, to overcome tumor tolerance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The use of robotic surgery for the management of urethral strictures and bladder neck contractures: A systematic review.

Actas urologicas espanolas·2024
Same author

Use of Multiparametric and Biparametric Magnetic Resonance Imaging in Bladder Cancer Staging: Prospective Observational Study and Analysis of Radiologist Learning Curve.

Journal of clinical medicine·2024
Same author

An international delphi survey and consensus meeting to define the risk factors for ureteral stricture after endoscopic treatment for urolithiasis.

World journal of urology·2024
Same author

The impact of mpMRI-targeted vs systematic biopsy on the risk of prostate cancer downgrading at final pathology.

World journal of urology·2024
Same author

Ureteral stricture rate after endoscopic treatments for urolithiasis and related risk factors: systematic review and meta-analysis.

World journal of urology·2024
Same author

Robot-assisted partial nephrectomy using the novel Hugo™ RAS system: Feasibility, setting and perioperative outcomes of the first off-clamp series.

Urologia·2024

Area of Science:

  • Oncology
  • Immunology
  • Urology

Background:

  • Prostate cancer (PCa) development is strongly linked to hormonal factors.
  • Emerging evidence indicates PCa significantly influences the host immune system.
  • This review examines PCa's complex interactions with immunity.

Purpose of the Study:

  • To review factors influencing the immune system in prostate cancer patients.
  • To highlight the potential of immunotherapy for prostate cancer treatment.
  • To report recent advancements in prostate cancer immunotherapy.

Main Methods:

  • Literature review of studies on prostate cancer and the immune system.
  • Analysis of factors such as PSA, hormones, inflammation, and growth factors.
  • Examination of current and emerging immunotherapeutic strategies.

Related Experiment Videos

Main Results:

  • Various factors (PSA, hormones, inflammation, cytokines, etc.) modulate the immune response in PCa.
  • Prostate cancer cells can induce host immune tolerance.
  • Immunotherapy is a promising therapeutic avenue for PCa.

Conclusions:

  • Prostate cancer's interaction with the immune system is multifaceted.
  • Overcoming immune tolerance is crucial for effective PCa treatment.
  • Gene therapy, monoclonal antibodies, and vaccines represent key advances in PCa immunotherapy.